Clinical Trials Directory

Trials / Completed

CompletedNCT02495402

Substance Abuse Treatment to HIV Care (SAT2HIV): The Motivational Interviewing-based Brief Intervention Experiment

Substance Abuse Treatment to HIV Care (SAT2HIV): The Motivational Interviewing-based Brief Intervention (MIBI) Experiment

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
827 (actual)
Sponsor
RTI International · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Accepted

Summary

To test the effectiveness of a single 20-30 minute motivational interviewing-based brief intervention for substance use within HIV/AIDS settings.

Detailed description

The Substance Abuse Treatment to HIV care (SAT2HIV) project, a Type 2 Effectiveness-Implementation Hybrid Trial, seeks to address this gap in services by providing new knowledge regarding the effectiveness of brief intervention (BI) for substance use within community-based HIV/AIDS service settings, as well as new knowledge regarding how to address the well-documented underutilization of evidence-based practices in real-world settings. The specific aims of this project are: Aim 1: To experimentally test the effectiveness of a motivational interviewing-based BI for substance use within community-based HIV/AIDS service organizations, relative to usual care (UC). Aim 2: To experimentally test the effectiveness of adding an organizational-level implementation intervention called Implementation \& Sustainment Facilitation (ISF) to enhance the effectiveness of the implementation strategy currently used by SAMHSA-funded Addiction Technology Treatment Centers (ATTCs; i.e., online introductory training, 2-day training workshop, ongoing feedback and coaching).

Conditions

Interventions

TypeNameDescription
BEHAVIORALMotivational InterviewingParticipants assigned to the experimental condition receive a single 20-30 minute motivational interviewing-based brief intervention for substance use.

Timeline

Start date
2015-07-08
Primary completion
2017-12-28
Completion
2018-03-25
First posted
2015-07-13
Last updated
2018-05-09

Locations

39 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02495402. Inclusion in this directory is not an endorsement.